Skip to main content
Top
Published in: Trials 1/2024

Open Access 01-12-2024 | Study protocol

Preoperative supine time for adrenal venous sampling: a prospective randomized controlled trial

Authors: Minzhi He, Yuhao Zhang, Xiaoxiao Song, Tianyue Zhang, Hailan Yu, Yongli Ji, Siyuan Gong, Peifei Chai, Jinyi Chen, Siwei Wang, Bing Chen, Xiaohong Xu, Zhenjie Liu

Published in: Trials | Issue 1/2024

Login to get access

Abstract

Background

Primary aldosteronism (P.A.) is the most common form of secondary hypertension, accounting for 5% of hypertensive patients and 17–23% of patients with resistant hypertension. Compared to primary hypertension, P.A. is more prone to cause severe organ damage and even early death. Adrenal venous sampling (AVS) is a practical confirmatory test for subtyping aldosterone-producing adenoma and bilateral adrenal hyperplasia, helping physicians to make an accurate decision between surgery or medication. According to guidelines, supine in bed before AVS is recommended for a desirable result of AVS. However, investigations about the most optimal preoperative supine time before AVS are lacking.

Methods/design

This is a multi-center prospective randomized controlled study. One hundred twenty patients diagnosed as P.A. and willing for AVS examination will be included. Participants will be randomly allocated to a 15-min supine time group or 2-h supine time group. The primary outcome is the degree of biochemical remission (serum potassium and orthostatic ARR). The secondary outcomes are degrees of clinical remission (blood pressure, type and dose of antihypertensive drugs), the technical success rate, and the adverse event of AVS (selective index ≥ 2 is considered successful surgery without corticotropin stimulation).

Discussion

P.A. is an intractable public health problem, and many techniques including AVS have been developed to identify this disease correctly. This study will help to understand whether the length of preoperative supine time would affect the diagnostic efficacy of AVS and thus help to formulate a more reasonable AVS procedure.

Trial registration

ClinicalTrials.gov NCT05658705. Registered on 10 September 2022.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol. 2020;16:578–89.CrossRefPubMed Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol. 2020;16:578–89.CrossRefPubMed
2.
go back to reference Conn JW. Presidential address. I. Painting background. Ii. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:3–17.PubMed Conn JW. Presidential address. I. Painting background. Ii. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:3–17.PubMed
3.
go back to reference Kaplan NM. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med. 1967;66:1079–90.CrossRefPubMed Kaplan NM. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med. 1967;66:1079–90.CrossRefPubMed
4.
go back to reference Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293–300.CrossRefPubMed Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293–300.CrossRefPubMed
5.
go back to reference Calhoun DA. Is there an unrecognized epidemic of primary aldosteronism? Pro Hypertension. 2007;50:447–53.CrossRefPubMed Calhoun DA. Is there an unrecognized epidemic of primary aldosteronism? Pro Hypertension. 2007;50:447–53.CrossRefPubMed
6.
go back to reference Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary aldosteronism in patients in China with recently detected hypertension. J Am Coll Cardiol. 2020;75:1913–22.CrossRefPubMed Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary aldosteronism in patients in China with recently detected hypertension. J Am Coll Cardiol. 2020;75:1913–22.CrossRefPubMed
7.
go back to reference Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013;62:331–6.CrossRefPubMed Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013;62:331–6.CrossRefPubMed
8.
go back to reference Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev. 2018;39:1057–88.CrossRefPubMedPubMedCentral Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev. 2018;39:1057–88.CrossRefPubMedPubMedCentral
9.
go back to reference Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285:126–48.CrossRefPubMed Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285:126–48.CrossRefPubMed
10.
go back to reference Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocrinol Metab. 2010;95:1360–4.CrossRefPubMed Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocrinol Metab. 2010;95:1360–4.CrossRefPubMed
11.
go back to reference Williams TA, JWM L, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689–99.CrossRefPubMedPubMedCentral Williams TA, JWM L, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689–99.CrossRefPubMedPubMedCentral
12.
go back to reference Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9:876–92.CrossRefPubMed Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9:876–92.CrossRefPubMed
13.
go back to reference Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–916.CrossRefPubMed Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–916.CrossRefPubMed
14.
go back to reference Zhong S, Zhang T, He M, Yu H, Liu Z, Li Z, et al. Recent advances in the clinical application of adrenal vein sampling. Front Endocrinol (Lausanne). 2022;13:797021.CrossRefPubMedPubMedCentral Zhong S, Zhang T, He M, Yu H, Liu Z, Li Z, et al. Recent advances in the clinical application of adrenal vein sampling. Front Endocrinol (Lausanne). 2022;13:797021.CrossRefPubMedPubMedCentral
15.
go back to reference Liu Z, He M, Song X, Xu F, Zhang B, Chen B, et al. Computed tomography image fusion, coaxial guidewire technique, fast intraprocedural cortisol testing technique improves success rate and decreases radiation exposure, procedure time, and contrast use for adrenal vein sampling. J Hypertens. 2021;39:1918–25.CrossRefPubMed Liu Z, He M, Song X, Xu F, Zhang B, Chen B, et al. Computed tomography image fusion, coaxial guidewire technique, fast intraprocedural cortisol testing technique improves success rate and decreases radiation exposure, procedure time, and contrast use for adrenal vein sampling. J Hypertens. 2021;39:1918–25.CrossRefPubMed
16.
go back to reference Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 2015;116:960–75.CrossRef Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 2015;116:960–75.CrossRef
17.
go back to reference Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63:151–60.CrossRefPubMed Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63:151–60.CrossRefPubMed
18.
go back to reference Seccia TM, Miotto D, Battistel M, Motta R, Barisa M, Maniero C, et al. A stress reaction affects assessment of selectivity of adrenal venous sampling and of lateralization of aldosterone excess in primary aldosteronism. Eur J Endocrinol. 2012;166:869–75.CrossRefPubMed Seccia TM, Miotto D, Battistel M, Motta R, Barisa M, Maniero C, et al. A stress reaction affects assessment of selectivity of adrenal venous sampling and of lateralization of aldosterone excess in primary aldosteronism. Eur J Endocrinol. 2012;166:869–75.CrossRefPubMed
19.
go back to reference Zheng Y, Long T, Peng N, Zhen M, Ye Q, Zhang Z, et al. The value of targeting cxcr4 with 68ga-pentixafor pet/ct for subtyping primary aldosteronism. J Clin Endocrinol Metab. 2023:dgad421. Zheng Y, Long T, Peng N, Zhen M, Ye Q, Zhang Z, et al. The value of targeting cxcr4 with 68ga-pentixafor pet/ct for subtyping primary aldosteronism. J Clin Endocrinol Metab. 2023:dgad421.
20.
go back to reference Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371:1921–6.CrossRefPubMed Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371:1921–6.CrossRefPubMed
22.
go back to reference Mulatero P, Sechi LA, Williams TA, Lenders JWM, Reincke M, Satoh F, et al. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38:1929–36.CrossRefPubMed Mulatero P, Sechi LA, Williams TA, Lenders JWM, Reincke M, Satoh F, et al. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38:1929–36.CrossRefPubMed
23.
go back to reference Betz MJ, Zech CJ. Adrenal venous sampling in the diagnostic workup of primary aldosteronism. Br J Radiol. 2022;95:20210311.CrossRefPubMed Betz MJ, Zech CJ. Adrenal venous sampling in the diagnostic workup of primary aldosteronism. Br J Radiol. 2022;95:20210311.CrossRefPubMed
24.
go back to reference Law R, Clow A. Stress, the cortisol awakening response and cognitive function. Int Rev Neurobiol. 2020;150:187–217.CrossRefPubMed Law R, Clow A. Stress, the cortisol awakening response and cognitive function. Int Rev Neurobiol. 2020;150:187–217.CrossRefPubMed
Metadata
Title
Preoperative supine time for adrenal venous sampling: a prospective randomized controlled trial
Authors
Minzhi He
Yuhao Zhang
Xiaoxiao Song
Tianyue Zhang
Hailan Yu
Yongli Ji
Siyuan Gong
Peifei Chai
Jinyi Chen
Siwei Wang
Bing Chen
Xiaohong Xu
Zhenjie Liu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Trials / Issue 1/2024
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-023-07872-2

Other articles of this Issue 1/2024

Trials 1/2024 Go to the issue